Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05774470 · ClinicalTrials.gov registry record
Bradycardia Recognition and Detection in Young Infants Part-I
A clinical trial of Hypoxemia of Newborn and Neonatal Bradycardia, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT05774470 is a study of Hypoxemia of Newborn and Neonatal Bradycardia that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05774470, a study of Hypoxemia of Newborn and Neonatal Bradycardia, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective cohort study will determine the diagnostic accuracy of the Owlet OSS 3.0 monitor for the detection of episodes of bradycardia and/or hypoxemia among infants.
Conditions Studied
Interventions
- DEVICE Owlet OSS 3.0
Study Locations (1)
Alabama
- UAB Hospital - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-04-22 |
| Est. Completion | 2023-07-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05774470
The ClinicalTrials.gov registry entry for NCT05774470 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypoxemia of Newborn appearing as the primary indexed condition, and to 1 intervention - of which Owlet OSS 3.0 is the first listed.
NCT05774470 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT05774470 about?
NCT05774470 is a clinical study titled "Bradycardia Recognition and Detection in Young Infants Part-I". This prospective cohort study will determine the diagnostic accuracy of the Owlet OSS 3.0 monitor for the detection of episodes of bradycardia and/or hypoxemia among infants.
What is the current status of trial NCT05774470?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2023-04-22. Estimated completion is 2023-07-29.
What conditions does trial NCT05774470 study?
This clinical trial studies the following conditions: Hypoxemia of Newborn, Neonatal Bradycardia.
What interventions are being tested in trial NCT05774470?
The interventions under investigation include: Owlet OSS 3.0 (DEVICE).
Who is sponsoring clinical trial NCT05774470?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05774470 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxemia of Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.